Clinical Significance of the Serum 3'tRF-AlaAGC, Neutrophil to High-Density Lipoprotein Ratio, and Lymphocyte-to-Monocyte Ratio in Breast Cancer with Lymph Node Metastasis.

IF 4.2 2区 医学 Q2 IMMUNOLOGY
Journal of Inflammation Research Pub Date : 2025-05-07 eCollection Date: 2025-01-01 DOI:10.2147/JIR.S518232
Dongping Mo, Yurong Zhu, Xuelian Mao, Cong Li, Yining Yang, Junyu Zheng, Feng Yan
{"title":"Clinical Significance of the Serum 3'tRF-AlaAGC, Neutrophil to High-Density Lipoprotein Ratio, and Lymphocyte-to-Monocyte Ratio in Breast Cancer with Lymph Node Metastasis.","authors":"Dongping Mo, Yurong Zhu, Xuelian Mao, Cong Li, Yining Yang, Junyu Zheng, Feng Yan","doi":"10.2147/JIR.S518232","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Breast cancer (BC) is a common malignant tumor among women, the local recurrence, lymph node metastasis (LNM), and distant metastasis are the key factors affecting the prognosis of patients. tRNA-derived small RNAs (tDRs) are non-coding small RNA fragments [16-40 nucleotides (nt) in length] that play an important role in carcinogenesis and can serve as novel biological markers for the diagnosis and prognosis of various tumors. Accumulating evidence suggests that blood-based inflammatory indicators are linked with the pathogenesis of BC. However, the clinical significance of the combination of tDRs and inflammatory indicators in BC patients with LNM is still unclear.</p><p><strong>Methods: </strong>The serum samples were collected from 175 patients with BC admitted to our hospital during June 2021 and May 2024, and 94 age-matched healthy women, and the clinical data of the research subjects were recorded. Serum 3'tRF-AlaAGC levels were measured using quantitative real-time PCR (qRT-PCR) and the blood-based inflammatory indicators were calculated from peripheral blood samples. Lasso-cox regression and multiple logistic regression were employed for variable selection. Receiver operating characteristic (ROC) was used to calculate the cut-off value of variables. Spearman correlation test was used to examine the correlation between 3'tRF-AlaAGC levels and neutrophil to HDL-C ratio (NHR), lymphocyte-to-monocyte ratio (LMR). A nomogram model for risk assessment of LNM in BC was established by using the rms package of R software.</p><p><strong>Results: </strong>Serum 3'tRF-AlaAGC levels in BC patients with LNM were significantly higher than that in without LNM [5.17 (1.79, 16.55) vs 11.68 (2.64, 58.74), <i>P</i>=0.009]. The variables screened by Lasso-cox regression including 3'tRF-AlaAGC, NHR and LMR, with optimal cut-off values of 18.78, 2.94 and 5.41, respectively. NHR levels were significantly negatively associated with LMR in low 3'tRF-AlaAGC expression groups (<i>r</i>=-0.209, <i>P</i>=0.021). Multivariate logistic regression analysis confirmed that 3'tRF-AlaAGC (OR: 3.242, 95% CI: 1.583-6.641, <i>P</i>=0.001), NHR (OR: 3.305, 95% CI: 1.543-7.079, <i>P</i>=0.002), and LMR (OR: 0.329, 95% CI: 0.150-0.723, <i>P</i>=0.006) were independent risk factors of BC with LNM. The C-statistic of the nomograms model was 0.704, with a sensitivity of 57.14% and a specificity of 77.14%.</p><p><strong>Conclusion: </strong>3'tRF-AlaAGC >18.78, NHR > 2.94, and LMR ≤ 5.41 were the independent risk factors of BC with LNM. The nomogram model incorporating 3'tRF-AlaAGC, NHR and LMR can effectively predict the risk of LNM of BC patients.</p>","PeriodicalId":16107,"journal":{"name":"Journal of Inflammation Research","volume":"18 ","pages":"5979-5991"},"PeriodicalIF":4.2000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12067465/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inflammation Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JIR.S518232","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Breast cancer (BC) is a common malignant tumor among women, the local recurrence, lymph node metastasis (LNM), and distant metastasis are the key factors affecting the prognosis of patients. tRNA-derived small RNAs (tDRs) are non-coding small RNA fragments [16-40 nucleotides (nt) in length] that play an important role in carcinogenesis and can serve as novel biological markers for the diagnosis and prognosis of various tumors. Accumulating evidence suggests that blood-based inflammatory indicators are linked with the pathogenesis of BC. However, the clinical significance of the combination of tDRs and inflammatory indicators in BC patients with LNM is still unclear.

Methods: The serum samples were collected from 175 patients with BC admitted to our hospital during June 2021 and May 2024, and 94 age-matched healthy women, and the clinical data of the research subjects were recorded. Serum 3'tRF-AlaAGC levels were measured using quantitative real-time PCR (qRT-PCR) and the blood-based inflammatory indicators were calculated from peripheral blood samples. Lasso-cox regression and multiple logistic regression were employed for variable selection. Receiver operating characteristic (ROC) was used to calculate the cut-off value of variables. Spearman correlation test was used to examine the correlation between 3'tRF-AlaAGC levels and neutrophil to HDL-C ratio (NHR), lymphocyte-to-monocyte ratio (LMR). A nomogram model for risk assessment of LNM in BC was established by using the rms package of R software.

Results: Serum 3'tRF-AlaAGC levels in BC patients with LNM were significantly higher than that in without LNM [5.17 (1.79, 16.55) vs 11.68 (2.64, 58.74), P=0.009]. The variables screened by Lasso-cox regression including 3'tRF-AlaAGC, NHR and LMR, with optimal cut-off values of 18.78, 2.94 and 5.41, respectively. NHR levels were significantly negatively associated with LMR in low 3'tRF-AlaAGC expression groups (r=-0.209, P=0.021). Multivariate logistic regression analysis confirmed that 3'tRF-AlaAGC (OR: 3.242, 95% CI: 1.583-6.641, P=0.001), NHR (OR: 3.305, 95% CI: 1.543-7.079, P=0.002), and LMR (OR: 0.329, 95% CI: 0.150-0.723, P=0.006) were independent risk factors of BC with LNM. The C-statistic of the nomograms model was 0.704, with a sensitivity of 57.14% and a specificity of 77.14%.

Conclusion: 3'tRF-AlaAGC >18.78, NHR > 2.94, and LMR ≤ 5.41 were the independent risk factors of BC with LNM. The nomogram model incorporating 3'tRF-AlaAGC, NHR and LMR can effectively predict the risk of LNM of BC patients.

乳腺癌伴淋巴结转移患者血清3′trf - alaagc、中性粒细胞/高密度脂蛋白比值、淋巴细胞/单核细胞比值的临床意义
目的:乳腺癌(Breast cancer, BC)是女性常见的恶性肿瘤,其局部复发、淋巴结转移(lymph node metastasis, LNM)及远处转移是影响患者预后的关键因素。trna衍生小RNA (tRNA-derived small RNAs, tDRs)是一种长度为16-40个核苷酸的非编码小RNA片段,在肿瘤发生过程中发挥重要作用,可作为多种肿瘤诊断和预后的新型生物学标志物。越来越多的证据表明,基于血液的炎症指标与BC的发病机制有关。然而,tDRs联合炎症指标在BC合并LNM患者中的临床意义尚不清楚。方法:采集我院2021年6月至2024年5月收治的175例BC患者和94例年龄匹配的健康女性的血清样本,记录研究对象的临床资料。采用实时荧光定量PCR (qRT-PCR)检测血清3'tRF-AlaAGC水平,并从外周血样本计算血基炎症指标。采用Lasso-cox回归和多元逻辑回归进行变量选择。采用受试者工作特征(Receiver operating characteristic, ROC)计算变量的截止值。采用Spearman相关检验检测3'tRF-AlaAGC水平与中性粒细胞/ HDL-C比值(NHR)、淋巴细胞/单核细胞比值(LMR)的相关性。利用R软件的rms包,建立了BC省LNM风险评估的nomogram模型。结果:合并LNM的BC患者血清3′trf - alaagc水平显著高于未合并LNM的BC患者[5.17 (1.79,16.55)vs 11.68 (2.64, 58.74), P=0.009]。Lasso-cox回归筛选的变量包括3′trf - alaagc、NHR和LMR,最佳临界值分别为18.78、2.94和5.41。低3′trf - alaagc表达组NHR水平与LMR呈显著负相关(r=-0.209, P=0.021)。多因素logistic回归分析证实,3′trf - alaagc (OR: 3.242, 95% CI: 1.583-6.641, P=0.001)、NHR (OR: 3.305, 95% CI: 1.543-7.079, P=0.002)和LMR (OR: 0.329, 95% CI: 0.150-0.723, P=0.006)是BC合并LNM的独立危险因素。模态图模型的c统计量为0.704,敏感性为57.14%,特异性为77.14%。结论:3′trf - alaagc >18.78、NHR bbb_1 2.94、LMR≤5.41是BC合并LNM的独立危险因素。结合3′trf - alaagc、NHR和LMR的nomogram model可以有效预测BC患者发生LNM的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Inflammation Research
Journal of Inflammation Research Immunology and Microbiology-Immunology
CiteScore
6.10
自引率
2.20%
发文量
658
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信